ACE2 and B-cell chronic lymphocytic leukemia: An assay that measured Ab-mediated inhibition of the ACE2/RBD (Wuhan strain) interaction,22 yielded very similar results, detecting blockade in all controls, but in only 30% (28/95) of CLL patients (Tables S2 and S3).